Talecris Biotherapeutics (JOBS) Still Planning IPO

Published: Aug 03, 2009

PEHUB -- Talecris Biotherapeutics Holding Corp., a Research Triangle Park, N.C.-based developer of plasma-derived protein therapies, last month filed a pair of amendments to its original IPO filing. Neither amendment disclosed the number of shares to be offered or a price range, but did indicate that the company still plans to go public.

Back to news